Skip to main content
Log in

Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Fluorescent glycolipids were utilized for detection of the intracellular, activator-dependent, activities of β-glucocerebrosidase and arylsulphatase A. Activities were measured in primary skin fibroblasts from normal individuals, from patients with Gaucher disease who had mutations within the β-glucocerebrosidase gene, and from a prosaposin-deficient patient. Fluorescent microscopy demonstrated that glucosylceramide or sulphatide labelled with a fluorescent probe (lissamine-rhodamine) were endocytosed and reached the lysosomes. There, in the presence of active enzyme and the corresponding saposin, they were hydrolysed to fluorescent ceramide, which changed its intracellular localization. When these substrates were labelled with pH-sensitive lissamine-rhodamine, which loses its fluorescence at neutral or alkaline pH, the transport of the product, i.e. fluorescent ceramide, from the lysosomes resulted in disappearance of the cellular fluorescence. In cells of patients having mutations within the genes encoding the glucocerebrosidase or the prosaposin, there was a considerable reduction in the intracellular rate of substrate hydrolysis that could be followed by fluorescence microscopy or measured quantitatively in cell extracts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abrahamov A, Elstein D, Gross TV, et al (1995) Gaucher's disease variant characterized by progressive calcification of heart valves and unique genotype. Lancet 346: 1000–1003.

    PubMed  Google Scholar 

  • Agmon V, Monti E, Dagan A, Augusto P, Marchesini S, Gatt S (1993) Fluorescent-based diagnosis of lipid storage disease by analysis of the culture medium of skin fibroblasts. Clin Chim Acta 218: 139–147.

    PubMed  Google Scholar 

  • Agmon V, Khosravi R, Marchesini S, et al (1996) Intracellular degradation of sulforhodamine-GM1: use of a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells. Clin Chim Acta 247: 105–120.

    PubMed  Google Scholar 

  • Beutler E, Gelbart T (1998) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 24: 2–8.

    PubMed  Google Scholar 

  • Beutler E, Nguyen NJ, Henneberger MW, et al (1993) Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 52: 85–88.

    PubMed  Google Scholar 

  • Bradford MM (1976) A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248–254.

    Article  PubMed  Google Scholar 

  • Brady RO, Barranger JA (1983) Glucosylceramide lipidosis: Gaucher disease. In Stanbury JB, Wyngaarden JB, Fredrickson DS, et al, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 842–856.

    Google Scholar 

  • Brady RO, Kafner JN, Shapiro D (1965) Metabolism of glucocerebrosidase II. Evidence of an enzymatic deficiency in GaucherÏs disease. Biochem Biophys Res Commun 18 (2): 221–225.

    PubMed  Google Scholar 

  • Chatelut M, Leruth M, Harzer K, et al (1998) Natural ceramide is unable to escape the lysosome, in contrast to a Ñuorescent analogue. FEBS Lett 426: 102–106.

    PubMed  Google Scholar 

  • Eyal N, Wilder S, Horowitz M (1990) Prevalent and rare mutations among Gaucher patients. Gene 96: 277–283.

    PubMed  Google Scholar 

  • Gross-Tsur V, Har EY, Gutman I, Amir N (1989) Oculomotor apraxia: the presenting sign of Gaucher disease. Pediatr Neurol 5: 128–129.

    PubMed  Google Scholar 

  • Harzer K, Paton BC, Christomanou H, et al (1997) Saposins (sap) A and C activate the degradation of galactosylceramide in living cells. FEBS Lett 417: 270–274.

    PubMed  Google Scholar 

  • Ho MW, O'Brien JS (1971) Gaucher's disease: deÐciency of ‘acid’-glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci USA 68: 2810–2813.

    PubMed  Google Scholar 

  • Horowitz M, Pasmanik-Chor M, Borochowitz Z, et al (1998) Prevalence of glucocerebrosidase mutations in the Israeli Jewish population. Hum Mutat 12: 240–244.

    PubMed  Google Scholar 

  • Leonova T, Qi X, Bencosme A, Ponce E, Sun Y, Grabowski GA (1996) Proteolytic processing patterns of prosaposin in insect and mammalian cells. J Biol Chem 271: 17312–17320.

    PubMed  Google Scholar 

  • Lipsky NG, Pagano RE (1983) Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a Ñuorescent ceramide analogue. Proc Natl Acad Sci USA 80: 2608–2612.

    PubMed  Google Scholar 

  • Lipsky NG, Pagano RE (1995) Intracellular translocation of fluorescent sphingolipids in cultured Ðbroblasts: endogenously synthesized sphingolipids and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane. J Cell Biol 100: 27–34.

    Google Scholar 

  • Marchesini S, Gatt S, Agmon V, Giudici ML, Monti E (1992) A novel Ñuorescent pH indicator for the acidic range. Biochem Int 27: 545–550.

    PubMed  Google Scholar 

  • Mehl E, Jatzkewitz H (1964) [A cerebrosidesulfatase from swine kidney]. Hoppe Seylers Z Physiol Chem 339: 260–276.

    PubMed  Google Scholar 

  • O'Brien JS, Kishimoto Y (1991) Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J 5: 301–308.

    PubMed  Google Scholar 

  • O'Brien JS, Carson GS, Seo HC, et al (1995) Identification of the neurotrophic factor sequence of prosaposin. FASEB J 9: 681–685.

    PubMed  Google Scholar 

  • Pasmanik-Chor M, Laadan S, Elroy-Stein O, et al (1996) The glucocerebrosidase D409H mutation in Gaucher disease. Biochem Mol Med 59: 125–133.

    PubMed  Google Scholar 

  • Paton BC, Schmid B, Kustermann KB, Poulos A, Harzer K (1992) Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase. Biochem J 285: 481–488.

    PubMed  Google Scholar 

  • Reiner O, Horowitz M (1988) Differential expression of the human glucocerebrosidase-coding gene. Gene 73: 469–478.

    PubMed  Google Scholar 

  • Sandhoff K, Harzer K, Furst W (1995) Sphingolipid activator proteins. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 2427–2441.

    Google Scholar 

  • Schnabel D, Schroder M, Furst M, et al (1992) Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem 267: 3312–3315.

    PubMed  Google Scholar 

  • Tsuji S, Choudary PV, Martin BM, et al (1987) A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med 316: 570–575.

    PubMed  Google Scholar 

  • Tsuji S, Martin BM, Barranger JA, Stubblefield BK, LaMarca ME, Ginns EI (1988) Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci USA 85: 2349–2352.

    PubMed  Google Scholar 

  • Zimran A, Gelbart T, Westwood B, Grabowski GA, Beutler E (1991) High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet 49: 855–859.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Madar-Shapiro, L., Pasmanik-Chor, M., Dinur, T. et al. Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators. J Inherit Metab Dis 22, 623–637 (1999). https://doi.org/10.1023/A:1005573812430

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005573812430

Keywords

Navigation